Pathology‐Triggered Cascade‐Responsive Implants for Converting Diabetic Microenvironment Signals Into Osteogenic Drivers
Advanced Healthcare Materials · 13.11.2026
DOI: 10.1002/adhm.71898 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 13.11.2026. Verfasst von Yizheng Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Polymer Science and Engineering, Dalian University of Technology, Dalian, China. Die Arbeit nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Dalian Science and Technology Innovation Fund.
Abstract (Originalsprache)
Hyperglycemia severely impairs implant osseointegration due to a hostile bone microenvironment of glycemic fluctuations and oxidative stress. Although responsive biomaterials can dynamically regulate pathological issues, converting harmful signals into a continuous driving force that promotes bone formation remains challenging. Herein, we present a cascade‐responsive poly(aryl ether sulfone ketone) (PPESK) implant designed to actively leverage pathological signals for bone regeneration. PPESK features a chitosan‐based surface modified with glucose oxidase (GOD), encapsulating black phosphorus (BP)‐based nanoparticles loaded with in situ mineralized IGF‐1 (mBI). Underlying this design is a glucose/pH/ROS cascade‐responsive mechanism where local glucose triggers the catalytic activity of GOD, leading to acid‐induced swelling of chitosan and subsequent exposure of mBI. Subsequently, the intrinsic oxidative responsiveness of BP to reactive oxygen species (ROS) facilitates the controlled release of IGF‐1. It not only utilizes pathological signal transduction for targeted drug delivery to enhance the osteogenic differentiation potential of BMSCs but also establishes a self‐regulated feedback path. By continuously consuming excess glucose and ROS, the implant improves the adverse local environment while promoting bone regeneration. Consequently, the PPESK implant accelerates bone remodeling in vivo, transforming the hyperglycemic microenvironment into an active driver for diabetic bone regeneration and offers a novel therapeutic strategy for stagnated bone repair.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Polymer Science and Engineering, Dalian University of Technology, Dalian, China.
- State Key Laboratory of Fine Chemicals, Frontier Science Center For Smart Materials, Dalian University of Technology, Dalian, China.
- Instrumental Analysis Center, Dalian University of Technology, Dalian, China.
- Department of Pharmacology, College of Medicine, Dalian University, Dalian, China.
- Laboratory Animal Center, Dalian Medical University, Dalian, China.
- Department of Psychiatry and Applied Psychology, Dalian Medical University, Dalian, China.
ORCID-Profile: Xitong Cheng, Chengde Liu, Rujiao Jiang, Xigao Jian
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Dalian Science and Technology Innovation Fund
- Postdoctoral Fellowship Program (Grade B) of China Postdoctoral Science Foundation
- Liaoning Provincial Natural Science Foundation Joint Fund
Zitieren
APA
Li, Y., Cheng, X., Liu, Y., Yuan, J., Yu, Y., Liu, C., Zhang, X., Jiang, R., Bin, J., & Jian, X. (2026). Pathology‐Triggered Cascade‐Responsive Implants for Converting Diabetic Microenvironment Signals Into Osteogenic Drivers. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71898
Vancouver
Li Y, Cheng X, Liu Y, Yuan J, Yu Y, Liu C, et al. Pathology‐Triggered Cascade‐Responsive Implants for Converting Diabetic Microenvironment Signals Into Osteogenic Drivers. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71898
BibTeX
@article{Li2026,
author = {Li, Yizheng and Cheng, Xitong and Liu, Yajie and Yuan, Jiayi and Yu, Yue and Liu, Chengde and Zhang, Xuemei and Jiang, Rujiao and Bin, Jiayi and Jian, Xigao},
title = {Pathology‐Triggered Cascade‐Responsive Implants for Converting Diabetic Microenvironment Signals Into Osteogenic Drivers},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71898}
}
EUVIMED